Franchise brand comparison
dermani MEDSPA vs 4Ever Young
Compared on figures each brand discloses in its own Franchise Disclosure Document — 2026 for dermani MEDSPA, 2026 for 4Ever Young. Investment, fees, and Item 19 gross sales, with the sample size behind every average.
Short answer
Two aesthetics franchises built on injectables, at similar entry costs: a $698,991 midpoint for dermani MEDSPA and $665,025 for 4Ever Young. On franchised results 4Ever Young is well ahead, $1,020,756 average and $862,165 median across 49 centers against dermani's $686,494 across 23, which is 1.53x capital efficiency against 0.98x. dermani's franchised system is younger, which explains part of the gap, and its five company spas average $1,698,249. Both disclose costs: dermani's company spas spend 35.2% of revenue on injectables and skin care, and 4Ever Young's 14 reporting franchised centers average about 30% cost of goods and $187,000 of adjusted net income. dermani's fees are lighter, 5% plus a marketing fee currently charged at 0.25%, against 4Ever Young's 7% royalty plus a brand fund. For proven franchised revenue, 4Ever Young; for a lighter fee load and company spas that set a high bar, dermani.
Side by side
| Measure | dermani MEDSPA | 4Ever Young |
|---|---|---|
| Concept category | Medical wellness | Medical wellness |
| FDD year | 2026 | 2026 |
| Total investment (Item 7) | $491,792–$906,189midpoint $698,991 | $522,650–$807,400midpoint $665,025 |
| Initial franchise fee | $55,000 | $60,000 |
| Royalty | 5% | 7% |
| Brand fund | up to 2% (currently 0.25%) | reported at 1–2% — see review |
| Local advertising | None disclosed separately | None disclosed separately |
| Average gross sales (Item 19) | $686,49423 units — franchised medspas, CY2025 | $1,020,75649 units — franchised centers open 12+ months at 12/31/2025, CY2025 |
| Median gross sales | Not disclosed | $862,165 |
| Top quartile | Not disclosed | Not disclosed |
| Bottom quartile | Not disclosed | Not disclosed |
| Revenue ÷ investment | 0.98x | 1.53x |
| Quartile spread | — | — |
Bolded figures mark the stronger side of a row where both brands disclose a comparable number — lower investment, higher revenue, higher return on capital, narrower quartile spread. A brand that discloses nothing is never marked as losing a row: an undisclosed figure is an unknown, not a poor result.
What the numbers mean
Investment is Item 7, the franchisor's own estimate of everything needed to open. dermani MEDSPA discloses a total initial investment of $491,792 to $906,189 in its 2026 FDD, a midpoint of $698,991, with an initial franchise fee of $55,000. 4Ever Young discloses a total initial investment of $522,650 to $807,400 in its 2026 FDD, a midpoint of $665,025, with an initial franchise fee of $60,000.
Revenue is Item 19, and the unit count matters as much as the figure. dermani MEDSPA reports average gross sales of $686,494 across 23 units (franchised medspas, CY2025). 4Ever Young reports average gross sales of $1,020,756 and a median of $862,165 across 49 units (franchised centers open 12+ months at 12/31/2025, CY2025).
Return on capital divides disclosed average sales by the midpoint investment. dermani MEDSPA returns 0.98x and 4Ever Young returns 1.53x. This measures capital efficiency, not profit — it says how much annual revenue each dollar of build-out buys, and says nothing about the margin either concept actually runs.
Full review
dermani MEDSPA
Cost, fees, and Item 19 revenue, reviewed against the 2026 FDD.
Full review
4Ever Young
Cost, fees, and Item 19 revenue, reviewed against the 2026 FDD.
Frequently asked
- dermani MEDSPA vs 4Ever Young: which is the better franchise?
- Two aesthetics franchises built on injectables, at similar entry costs: a $698,991 midpoint for dermani MEDSPA and $665,025 for 4Ever Young. On franchised results 4Ever Young is well ahead, $1,020,756 average and $862,165 median across 49 centers against dermani's $686,494 across 23, which is 1.53x capital efficiency against 0.98x. dermani's franchised system is younger, which explains part of the gap, and its five company spas average $1,698,249. Both disclose costs: dermani's company spas spend 35.2% of revenue on injectables and skin care, and 4Ever Young's 14 reporting franchised centers average about 30% cost of goods and $187,000 of adjusted net income. dermani's fees are lighter, 5% plus a marketing fee currently charged at 0.25%, against 4Ever Young's 7% royalty plus a brand fund. For proven franchised revenue, 4Ever Young; for a lighter fee load and company spas that set a high bar, dermani.
- How much does a dermani MEDSPA franchise cost compared to 4Ever Young?
- dermani MEDSPA discloses a total initial investment of $491,792 to $906,189 in its 2026 FDD, a midpoint of $698,991, with an initial franchise fee of $55,000. 4Ever Young discloses a total initial investment of $522,650 to $807,400 in its 2026 FDD, a midpoint of $665,025, with an initial franchise fee of $60,000.
- Does dermani MEDSPA or 4Ever Young generate more revenue?
- dermani MEDSPA reports average gross sales of $686,494 across 23 units (franchised medspas, CY2025). 4Ever Young reports average gross sales of $1,020,756 and a median of $862,165 across 49 units (franchised centers open 12+ months at 12/31/2025, CY2025). These are gross sales, not profit, and the number of units behind each average decides how much it tells you.
- What are the ongoing fees for dermani MEDSPA and 4Ever Young?
- dermani MEDSPA charges a royalty of 5% and a brand fund contribution of up to 2% (currently 0.25%). 4Ever Young charges a royalty of 7% and a brand fund contribution of reported at 1–2% — see review.
Other comparisons
Before you rely on any of this
FDDs are filed annually and figures move. Request the current document from each franchisor and read Items 5, 6, 7 and 19 yourself — this is a summary to orient you, not a substitute for the disclosure or for your own advisors. We are not affiliated with, endorsed by, or compensated by either brand; see our disclosure policy.
Compare every brand at once in the sortable cost comparison table, or run these figures against your own assumptions in the ROI & payback calculator.